BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6100286)

  • 1. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
    de-Thé G
    IARC Sci Publ; 1984; (63):727-44. PubMed ID: 6100286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus (EBV): a Rosetta Stone for understanding the role of viruses in immunopathological disorders and in human carcinogenesis.
    de-Thé G
    Biomed Pharmacother; 1985; 39(2):49-51. PubMed ID: 2990589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
    de-Thé G
    IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
    Henle W; Henle G
    Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
    Geser A; Brubaker G; Olwit GW
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
    Borisch-Chappuis B; Nezelof C; Müller H; Müller-Hermelink HK
    Am J Pathol; 1990 Apr; 136(4):751-8. PubMed ID: 1691592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
    Ambinder RF
    Hematol Oncol Clin North Am; 1990 Aug; 4(4):821-33. PubMed ID: 2172203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
    IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
    Nicholls JM; Agathanggelou A; Fung K; Zeng X; Niedobitek G
    J Pathol; 1997 Oct; 183(2):164-8. PubMed ID: 9390028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of human viruses in the pathogenesis of lymphoma.
    Lyons SF; Liebowitz DN
    Semin Oncol; 1998 Aug; 25(4):461-75. PubMed ID: 9728596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
    Levine PH
    Cancer Detect Prev Suppl; 1987; 1():217-23. PubMed ID: 2826001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and cancers of the head and neck.
    Goldenberg D; Golz A; Netzer A; Rosenblatt E; Rachmiel A; Goldenberg RF; Joachims HZ
    Am J Otolaryngol; 2001; 22(3):197-205. PubMed ID: 11351290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors.
    de-Thé G
    Cancer Res; 1976 Feb; 36(2 pt 2):692-5. PubMed ID: 1253156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses and cancer in man and subhuman primates.
    Ablashi DV; Easton JM; Guegan JH
    Biomedicine; 1976 Nov; 24(5):286-305. PubMed ID: 187259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carcinoma in Accra.
    Anim JT
    West Afr J Med; 1991; 10(2):121-6. PubMed ID: 1654999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.